XML 33 R18.htm IDEA: XBRL DOCUMENT v3.8.0.1
Note 12 - Income Taxes
12 Months Ended
Sep. 30, 2017
Notes to Financial Statements  
Income Tax Disclosure [Text Block]
12
.
INCOME TAXES
 
A reconciliation of the provision (recovery) of income taxes to the statutory federal income tax rate is as follows:
 
   
201
7
   
201
6
   
201
5
 
                         
Income (Loss) Before Provision for (Recovery of) Income Taxes
  $
2,188,760
    $
1,333,248
    $
(122,377
)
Statutory rate
   
34
%    
34
%    
34
%
Tax at statutory rate
 
   
744,178
     
453,304
     
(41,608
)
Permanent differences
   
5,465
     
1,000
     
900
 
Research and development and other credits - net
   
(77,220
)    
(47,400
)    
(48,500
)
Valuation allowance
   
-
     
(3,681,100
)    
82,200
 
State Tax
   
130,560
     
-
     
-
 
State Net Operating Loss
   
(174,223
)    
-
     
-
 
Transaction Costs
   
95,849
     
-
     
-
 
Other
   
55,755
     
(25,404
)    
7,008
 
Provision for (
recovery of) income taxes
  $
780,364
    $
(3,299,600
)   $
-
 
 

Deferred tax assets (liabilities) as of
September 30
consist of the following:
 
   
201
7
   
201
6
 
Inventories
  $
291,338
    $
302,600
 
Bad debts
   
21,171
     
3,400
 
Accrued liabilities
   
88,817
     
77,700
 
Prepaid expense
   
(73,120
)    
(8,900
)
Depreciation and amortization
   
220,967
     
93,000
 
Research and development and other credit carryforwards
   
2,179,462
     
2,019,700
 
Net operating loss carryforward
   
520,087
     
1,303,000
 
Directors stock option plan
   
41,537
     
40,100
 
Net deferred tax asset    
3,290,259
     
3,830,600
 
Valuation allowance
   
(500,000
)    
(500,000
)
Total
  $
2,790,259
    $
3,330,600
 
 
The Company did
not
incur any material impact to its financial condition or results of operations due to the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return.
 
Valuation Reserve

The valuation reserve remained at
$0.5
million at
September 30, 2017,
due to the likelihood that the Company will be profitable enough to utilize the majority of the net operating loss and research and development and other credit carryforwards.

Because of the uncertainties involved with this significant estimate, it is reasonably possible that the Company’s estimate
may
change in the near term.

Net Operating Loss Carryforwards:

 
The Company has federal and state net operating loss (NOL) and research and development (R&D) and other credit carryforwards for tax purposes which expire as follows:
 
Tax Year Expires
 
NOLS
   
R& D
& Other
Credits
 
2018
  $
-
    $
44,980
 
2019
   
-
     
166,019
 
2020
   
-
     
190,072
 
2021
   
-
     
126,620
 
2022
   
-
     
48,573
 
2023
   
-
     
107,172
 
2024
   
-
     
156,392
 
2025
   
-
     
155,394
 
2026
   
-
     
139,885
 
2027
   
-
     
154,991
 
2028
   
-
     
152,732
 
2029
   
-
     
68,676
 
2030
   
-
     
31,081
 
2031
   
302,190
     
44,712
 
2032
   
999,973
     
59,085
 
2033
   
1,155,716
     
71,062
 
2034
   
472,315
     
73,198
 
2035
   
99,688
     
76,429
 
2036
   
-
     
73,315
 
2037
   
-
     
117,000
 
2
038 and beyond
   
-
     
114,074
 
    $
3,029,882
    $
2,179,462